{
    "url_original": "https://www.wsj.com/articles/pfizer-biontech-covid-19-booster-shot-was-95-6-effective-in-large-trial-companies-say-11634823482?mod=business_lead_pos2",
    "url": "pfizer-biontech-covid-19-booster-shot-was-95-6-effective-in-large-trial-companies-say-11634823482",
    "title": "Pfizer-BioNTech Covid-19 Booster Shot Was 95.6% Effective in Large Trial, Companies Say",
    "sub_head": "The results came from testing in people while the contagious Delta variant was prevalent",
    "category_1": "Business",
    "category_2": "Health Care",
    "image_1_url": "https://images.wsj.net/im-421052?width=860&height=573",
    "image_1": "im-421052.jpg",
    "time": "2021-10-21 09:38:00"
}